A
Alnylam Pharmaceuticals
0
Latest Hiring Jobs
5
Clinical Trials
0
FDA Products
0
Publications
Company Overview
COMPANY TYPE
Pharmaceutical
INDUSTRIES
Unknown
HEADQUARTERS
WEBSITE
Not available
Clinical activity detected
This company has
10
clinical trial records
in the intelligence database.
Clinical Development
10 Trials
Recent clinical trial activity
| Trial | Phase | Status | Enrollment | Start Date | Condition |
|---|---|---|---|---|---|
|
NCT03547297
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP |
Observational | TERMINATED | - | - | Acute Hepatic Porphyria, Hepatic Porphyrias |
|
NCT03774784
A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease |
Observational | TERMINATED | - | - | Amyloidosis, Leukocyte Chemotactic Factor 2 Amyloidosis |
|
NCT02240784
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) |
Observational | COMPLETED | - | - | Acute Hepatic Porphyria |
|
NCT04982393
BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1) |
Observational | ACTIVE NOT RECRUITING | - | - | Primary Hyperoxaluria Type 1 |
|
NCT05040373
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program |
Observational | RECRUITING | - | - | Hereditary Transthyretin-mediated (hATTR) Amyloidosis, Polyneuropathy |
Company Intelligence
Company profile enrichment is not available yet.
Hiring Intelligence
Latest open positions detected for this company
No current hiring positions found.
FDA Regulatory Intelligence
0 Signals
FDA product and regulatory signals
No FDA regulatory data available.